Log in to your IBTimes Account

close
ID
Password

Asterand to acquire BioSeek



18 November 2009 @ 09:11 am BST

Asterand has signed an agreement to acquire BioSeek, a pioneer in the application of predictive human biology to drug discovery through its human primary cell based disease models.

The deal is subject to Asterand shareholders' approval. Asterand said it achieved revenue of 9.1m in the nine months to the end of September compared with 8m last year - excluding the licensing payments from Allergan.

Revenues for the same period last year also contained 1.1m relating to a one year contract that ended in December 2008.

The company said it continued to control its expenditures while maintaining strong cash resources of 5.2m (30 June: 5.8m).

Story provided by Business Financial Newswire

© 2009 BFNNews.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


advertisement
advertisement

Real Time Economic & Market Headlines

Ransquawk news

More Real-time news »

More Markets
END-OF-DAY REPORT: Headline shares ended the day comfortably higher, with better-than-expected UK unemployment data helping lift spirits, and with softwa...
Pharmaceutical firm Alliance Pharma has completed the transfer of a distribution agreement with Biovail Laboratories for the drug tetrabenazine.This is ...
University IP commercialisation firm FUSION IP has announced the launch of a new research tissue bank by one of its portfolio companies.It said Abcellute...

 
 
IBTimes © 2010 The IBTimes Company Ltd. All Rights Reserved. Partners